skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Sequential half-body irradiation as systemic treatment of progressive Ewing sarcoma

Journal Article · · Int. J. Radiat. Oncol., Biol. Phys.; (United States)

Sequential half-body irradiation (HBI) to be delivered in two session was used in 18 consecutive patients with metastastic Ewing sarcoma who relapsed after radiotherapy and multidrug chemotherapy. The HIB program to both upper and lower hemi body was completed in 11 patients (61%). The remaining 7 patients received only one single treatment of HBI because of relapse before the completion of the treatment program. In 20 of the 29 sessions HBI was employed to treat overt metastases. The overall objective response rate was 50%. Six of 18 patients (33%) are alive from 4 to 27 months, 3 of them without evidence of disease. No severe toxicity was observed. HBI as systemic treatment was more effective in patients who relapsed while off chemotherapy, with metatases confined to the lungs or to one single bone segment.

Research Organization:
Istituto Nazionale per lo Studio e la Cura dei Tumori Via Venezian, Milan, Italy
OSTI ID:
5464950
Journal Information:
Int. J. Radiat. Oncol., Biol. Phys.; (United States), Vol. 8:10
Country of Publication:
United States
Language:
English